Does SODIUM, MONOBASIC, ANHYDROUS Cause Hyperphosphataemia? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hyperphosphataemia have been filed in association with SODIUM, MONOBASIC, ANHYDROUS. This represents 8.2% of all adverse event reports for SODIUM, MONOBASIC, ANHYDROUS.
6
Reports of Hyperphosphataemia with SODIUM, MONOBASIC, ANHYDROUS
8.2%
of all SODIUM, MONOBASIC, ANHYDROUS reports
6
Deaths
6
Hospitalizations
How Dangerous Is Hyperphosphataemia From SODIUM, MONOBASIC, ANHYDROUS?
Of the 6 reports, 6 (100.0%) resulted in death, 6 (100.0%) required hospitalization, and 5 (83.3%) were considered life-threatening.
Is Hyperphosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SODIUM, MONOBASIC, ANHYDROUS. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does SODIUM, MONOBASIC, ANHYDROUS Cause?
Vomiting (21)
Abdominal distension (20)
Methaemoglobinaemia (20)
Stress (17)
Abdominal pain (16)
Appendicitis (16)
Appendicolith (16)
Ascites (16)
Hyponatraemia (16)
Cardiogenic shock (15)
What Other Drugs Cause Hyperphosphataemia?
ALLOPURINOL (139)
LANSOPRAZOLE (138)
ACETAMINOPHEN (132)
SEVELAMER (129)
ONDANSETRON (127)
CALCITRIOL (125)
IPRATROPIUM (123)
ALBUTEROL (122)
METRONIDAZOLE (120)
HYDROMORPHONE (118)